Table 3.
Feedback of the evaluation cycles
| Evaluation cycle | Feedback | ||
|---|---|---|---|
| I | II | III | |
| X | X | More user involvement | |
| X | Cross-border functionality within Europe | ||
| X | Participation in events should be possible, and the user should receive notifications | ||
| X | X | There must be a solution for people with older smartphone models | |
| X | X | Connecting labs for all test results | |
| X | More content information to lower data security concerns | ||
| X | X | At-work mode (e.g., for highly virus-protected health staff) | |
| X | X | General health application (e.g., gathering vital data, such as pulse, etc.) | |
| X | Vaccination integration | ||
| X | Push notification for crowd sensitivity and mask obligation | ||
| X | Create awareness for diseases | ||
| X | X | X | Overview about local coronavirus regulations |
| X | X | X | Overview about global coronavirus situation (e.g., infections) |
| X | Capacity and utilization of test center | ||
| X | X | Details about risk contacts (also in graphical representation) | |
| X | Details about the meaning from when a risk contact has been hit | ||
| X | Symptom tracking must have pre-formulated the most common symptoms and the degree of intensity | ||
| X | Settings page in CWA: user must control the degree of data sharing | ||